… Clin Cancer Res 15:485–491. Crossref, Medline, Google … of BRAF mutation in metastasized
papillary thyroid cancer in … of BRAF mutation in metastasized papillary thyroid cancer in …

… The beginning of 2000 marked the interest in BRAF gene mutation in thyroid cancer. At that
time studies on the role of the mutation in other cancers (eg, melanoma, colon cancer) had …

… a large series of 208 papillary thyroid cancers (PTC) followed … genetic alterations, including
point mutations and fusions. … V600E and TERT promoter mutations being the most frequent …

… promoter mutations in papillary thyroid cancer (PTC) has been recently established, but the
role of RAS mutation in this genetic interplay remains to be established. Using The Cancer …

… thyroid cancer, such as anaplastic thyroid cancer and poorly differentiated thyroid cancer, as
well as BRAF V600E mutation… V600E and TERT C228T mutations may cooperatively form a …

… mutation is not a determinant of the metastatic potential of PTC. Papillary thyroid cancers are
… determine the most appropriate use of the BRAF mutation as a clinical marker, whereas we …

… We generated a thyroid-specific CreER transgenic mouse … )-mutant papillary thyroid cancer
to anaplastic thyroid cancer (ATC)… lacking mouse model of BRAF-mutant ATC and adds to the …

… thyroid cancers are classified into papillary thyroid cancer (PTC), follicular thyroid cancer (FTC),
and anaplastic thyroid cancer (ATC)… for 85–90% of all thyroid malignancies.Differentiated …

… Background: Thyroid cancer (TC) has one of the fastest increasing incidences worldwide
and primarily involves papillary thyroid cancer (PTC). The BRAFV600E mutation is the most …

… marker for thyroid cancer, and a synergistic association with the BRAF V600E mutation has
… The aim of this study was to verify the role of this genetic duet in papillary thyroid cancer (…